Ingrid Bugáňová

1.5k total citations
2 papers, 385 citations indexed

About

Ingrid Bugáňová is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Ingrid Bugáňová has authored 2 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Endocrinology, Diabetes and Metabolism, 1 paper in Surgery and 1 paper in Molecular Biology. Recurrent topics in Ingrid Bugáňová's work include Lipoproteins and Cardiovascular Health (1 paper), Cancer, Lipids, and Metabolism (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). Ingrid Bugáňová is often cited by papers focused on Lipoproteins and Cardiovascular Health (1 paper), Cancer, Lipids, and Metabolism (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). Ingrid Bugáňová collaborates with scholars based in Slovakia, Denmark and Netherlands. Ingrid Bugáňová's co-authors include T Le-Thi, Rob H.A. Verhoeven, Thure Krarup, Ole Schmitz, Sten Madsbad, Milan Zdravkovic, Tina Vilsbøll, J.P. Courrèges, Ľubomíra Fábryová and Miriam Kozárová and has published in prestigious journals such as Diabetes Care and Atherosclerosis.

In The Last Decade

Ingrid Bugáňová

2 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ingrid Bugáňová Slovakia	2	337	182	181	93	50	2	385
T Le-Thi Denmark	2	498 1.5×	284 1.6×	283 1.6×	126 1.4×	62 1.2×	2	563
Deon Doree United States	9	208 0.6×	120 0.7×	171 0.9×	53 0.6×	33 0.7×	11	314
Christine Roy-Duval United States	4	440 1.3×	188 1.0×	137 0.8×	85 0.9×	58 1.2×	6	470
Surya Panicker Rajeev United Kingdom	7	232 0.7×	108 0.6×	107 0.6×	54 0.6×	49 1.0×	14	285
Mads M. Helsted Denmark	7	277 0.8×	142 0.8×	156 0.9×	48 0.5×	68 1.4×	16	348
Elisa P. Jensen Denmark	8	258 0.8×	89 0.5×	159 0.9×	42 0.5×	48 1.0×	10	322
Jonathan W. Day United States	8	220 0.7×	129 0.7×	108 0.6×	42 0.5×	48 1.0×	11	333
Terry Ridge United States	5	400 1.2×	174 1.0×	153 0.8×	114 1.2×	31 0.6×	8	416
J.P. Courrèges France	5	672 2.0×	338 1.9×	308 1.7×	171 1.8×	75 1.5×	7	734
Chay Ngee Lim United States	7	218 0.6×	125 0.7×	168 0.9×	32 0.3×	31 0.6×	11	319

Countries citing papers authored by Ingrid Bugáňová

Since Specialization

Citations

This map shows the geographic impact of Ingrid Bugáňová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Bugáňová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Bugáňová more than expected).

Fields of papers citing papers by Ingrid Bugáňová

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Bugáňová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Bugáňová. The network helps show where Ingrid Bugáňová may publish in the future.

Co-authorship network of co-authors of Ingrid Bugáňová

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Bugáňová. A scholar is included among the top collaborators of Ingrid Bugáňová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Bugáňová. Ingrid Bugáňová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

2 of 2 papers shown

1.

Vohnout, Branislav, Ľubomíra Fábryová, Alexander Klabník, et al.. (2018). Treatment pattern of familial hypercholesterolemia in Slovakia: Targets, treatment and obstacles in common practice. Atherosclerosis. 277. 323–326. 5 indexed citations

2.

Vilsbøll, Tina, Milan Zdravkovic, T Le-Thi, et al.. (2007). Liraglutide, a Long-Acting Human Glucagon-Like Peptide-1 Analog, Given as Monotherapy Significantly Improves Glycemic Control and Lowers Body Weight Without Risk of Hypoglycemia in Patients With Type 2 Diabetes. Diabetes Care. 30(6). 1608–1610. 380 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact